CholeraCholera ToxinCholera VaccinesDeveloping CountriesDeveloped CountriesVibrio choleraeVibrio cholerae O1HaitiG(M1) GangliosideEuropeBangladeshAntitoxinsToxoidsDisease OutbreaksVibrio cholerae O139World HealthIntestinal SecretionsEnterotoxinsSanitationAdenosine Diphosphate RiboseDiarrheaWorld Health OrganizationToxins, BiologicalInternational CooperationInternationalityIndiaAsiaAfricaEpidemicsAdministration, OralAdenylate CyclaseLatin AmericaCyclic AMPBacterial ToxinsCross-Cultural ComparisonVibrioPrevalencePhilippinesVaccinationAntibodies, BacterialPopulation SurveillanceMiddle EastIncidencePakistanImmunoglobulin AFecesEurope, EasternHistory, 19th CenturyGuinea-BissauInfant, NewbornEndemic DiseasesTravelImmunizationEuropean UnionClassical Swine FeverWater MicrobiologyVirulence Factors, BordetellaGangliosidesIleumAfrica South of the SaharaPertussis ToxinRisk FactorsUnited NationsHealth PolicySocioeconomic FactorsAdministration, IntranasalGTP-Binding ProteinsPeruDemocratic Republic of the CongoIntestinal MucosaWater SupplyTime FactorsCholera MorbusImmunity, MucosalVibrio cholerae non-O1Fluid TherapyHygieneZimbabweAsia, SoutheasternAmericasPublic HealthRabbitsRural PopulationJejunumEmigration and ImmigrationSeasonsScandinaviaGeographyTanzaniaPasteurella multocidaCross-Sectional StudiesAdenylate Cyclase ToxinNucleoside Diphosphate SugarsQuestionnairesImmunoglobulin A, SecretoryColforsinGhanaDominican RepublicAustraliaDelivery of Health Care